Fakhr Alayoubi, Dr

Clinical Pharmacist
KSUMC

FAKHR ZOHAIR ALAYOUBI, MSC,RPHARM,BHF,MBA.

Fakhr Z. Alayoubi, MSC, is a double-board certified Pediatric & Adult clinical poisoning management, Heart Failure specialist, and the president of Saudi pharmacy specialist group at the Saudi Heart Association, am intrested in the use of pharmacotherapy in clinical practice & metabolic syndrome.
My research team has published more than 20 scientific articles including the world’s largest pharmacy and metabolic syndrome study on Saudi population and gulf countries. I have a lot of afforts not only demonstrated on conducting clinical trials and multidisciplinary pregames as team work, but also in establishing as well as implementing different national guidelines, with the possibility of significant collaboration with MENA and Global Countries. My team was able to do the world’s largest international health care practitioners & health technology gathering in the pandemic era. and also established the Anti-coagulation group that is covering all national sites in Saudia Arabia.

Presentation(s):

• PB0999 - Update in The Management Tools of Thrombotic Thrombocytopenic Purpura(TTP) As One of the Rare Hematological Disorders with A Highlight On the Cost Value of Such Diseases

  Tuesday, July 12, 2022
  6:30 PM – 7:30 PM

• PO0016 - Covid 19 with Hematological presentation and complications that may lead to Stem cell transplant

  Wednesday, July 13, 2022
  1:00 PM – 2:00 PM

• PO0048 - A Cardiac Amyloidosis Presentation: Atrial Mass Versus Thrombus

  Wednesday, July 13, 2022
  1:00 PM – 2:00 PM

• PO0071 - Real World Data : Safety and Mortality Monitoring the patients on Rivaroxaban in our center

  Wednesday, July 13, 2022
  1:00 PM – 2:00 PM